Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma


Collapse Overview 
Collapse sponsor award id
NRG-BN007


Collapse Biography 

Collapse Time 
Collapse start date
2021-08-06

Collapse end date
2022-08-05